2026-03-19 • PR Newswire
Woori IO, a privately-held firm, has executed a non-disclosure agreement with Sinopharm regarding entry into the Chinese market and international multicenter clinical trials.
2026-03-19 • PR Newswire
Woori IO, a privately-held firm, has executed a non-disclosure agreement with Sinopharm regarding entry into the Chinese market and international multicenter clinical trials.2026-03-18 • gurufocus.com
Aldeyra’s ALDX Drug Application Receives FDA Rejection2026-03-18 • stocktitan.net
The FDA has denied Aldeyra’s NDA for reproxalap to treat dry eye.2026-03-18 • cancernetwork.com
FDA Accepts 18F-FET PET Imaging Agent Resubmission for Recurrent Glioma2026-03-18 • glance.eyesoneyecare.com
The FDA sent a complete response letter to Chiesi Global Rare Diseases concerning the company’s new drug application for oral idebenone to treat Leber hereditary optic neuropathy (LHON). This announcement2026-03-17 • stocktitan.net
FDA Accepts Cogent Biosciences’ New Drug Application for Bezuclastinib in NonAdvanced Systemic Mastocytosis Patients2026-03-17 • globenewswire.com
NRx Pharmaceuticals confirms its pathway to a new drug application supported by real world data and a wider proposed indication for NRX-100 ketamine after a Type C FDA meeting2026-03-16 • psychedelicnewswire.com
The FDA has provided guidance supporting the New Drug Application review for NRX-100 from NRx Pharmaceuticals, Inc. (NASDAQ: NRXP).2026-03-16 • pharmacytimes.com
The FDA denied the Valacyclovir Oral Suspension New Drug Application due to facility current Good Manufacturing Practice deficiencies.2026-03-16 • PR Newswire
Telix has again filed an NDA with the U.S. FDA for TLX101-Px the Pixclara® imaging drug for brain cancer.2026-03-11 • stocktitan.net
Mineralys Therapeutics Reports FDA Approval of Lorundrostat for Hypertension Patients and Shares Explore-OSA Trial Data2026-03-07 • gurufocus.com
Prime Medical Ventures Announces Successful Phase 2 Data, Preparing for 2027 FDA Filing2026-03-02 • libyaherald.com
Nova Global company is overseeing construction of Sebha’s Rose Palace Hotel, led by NDA2026-02-26 • glance.eyesoneyecare.com
FDA Policy Now Requires One Key Trial for New Drug Applications26 minutes ago • prnewswire.co.uk
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress26 minutes ago • prnewswire.co.uk
Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial27 minutes ago • prnewswire.co.uk
EQT AB publishes Annual & Sustainability Report for 20256 hours ago • prnewswire.co.uk
Deye’s 2026 Frankfurt Distributor and Partner Summit Ended Positively2026-03-21 • prnewswire.co.uk
Shareholder Lawsuit Filed Against Goeasy Ltd.11 minutes ago • EIN Presswire
Hughey Law Firm Surpasses $300 Million in Verdicts & Settlements, Nearly Half Recovered for Elder Abuse Injury Victims11 minutes ago • EIN Presswire
Premiere Screening of 'Love in Storytown' Comes to Historic Jackson Theatre on April 1211 minutes ago • EIN Presswire
Property Trade Network Launches Cash Offer Platform for Home SellersStay ahead with real-time headlines from top sources, categorized by sector and country.